Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: a subgroup analysis of age

被引:0
|
作者
Cohen, A. [1 ]
Sah, J. [2 ]
Dhamane, A. [3 ]
Lee, T. [4 ]
Rosenblatt, L. [3 ]
Hlavacek, P. [4 ]
Emir, B. [4 ]
Keshishian, A. [2 ]
Yuce, H. [5 ]
Luo, X. [6 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, Kings Coll London, Dept Med Hematol, London, England
[2] STATinMED Res, Ann Arbor, MI USA
[3] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[4] Pfizer Inc, New York, NY USA
[5] CUNY, New York City Coll Technol, New York, NY 10021 USA
[6] Pfizer Inc, Groton, CT USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1941 / 1941
页数:1
相关论文
共 50 条
  • [1] Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race
    Cohen, A.
    Sah, J.
    Dhamane, A.
    Lee, T.
    Rosenblatt, L.
    Hlavacek, P.
    Emir, B.
    Keshishian, A.
    Yuce, H.
    Luo, X.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1940 - 1940
  • [2] Effectiveness and Safety of Apixaban Vs Warfarin Among Venous Thromboembolism Patients Using Five US Databases: A Subgroup Analysis of Obesity
    Cohen, Alexander T.
    Sah, Janvi
    Lee, Theodore
    Wygant, Gail
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Delinger, Rachel
    Luo, Xuemei
    [J]. BLOOD, 2020, 136
  • [3] Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients using five US databases: a subgroup analysis of chronic liver disease
    Cohen, A.
    Sah, J.
    Dhamane, A.
    Lee, T.
    Rosenblatt, L.
    Hlavacek, P.
    Emir, B.
    Keshishian, A.
    Yuce, H.
    Luo, X.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1942 - 1942
  • [4] Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    [J]. PLOS ONE, 2022, 17 (09):
  • [5] Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale
    Cohen, Alexander T.
    Keshishian, Allison
    Lee, Theodore
    Wygant, Gail
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Mardekian, Jack
    Wiederkehr, Daniel
    Sah, Janvi
    Luo, Xuemei
    [J]. BLOOD, 2019, 134
  • [6] Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    [J]. ADVANCES IN THERAPY, 2021, 38 (11) : 5519 - 5533
  • [7] Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status
    Alexander T. Cohen
    Janvi Sah
    Amol D. Dhamane
    Theodore Lee
    Lisa Rosenblatt
    Patrick Hlavacek
    Birol Emir
    Allison Keshishian
    Huseyin Yuce
    Xuemei Luo
    [J]. Advances in Therapy, 2021, 38 : 5519 - 5533
  • [8] Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
    Cohen, Alexander
    Sah, Janvi
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (02) : 1 - 11
  • [9] Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Hines, Dionne M.
    Lee, Theodore
    Rosenblatt, Lisa
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    [J]. ADVANCES IN THERAPY, 2023, 40 (04) : 1705 - 1735
  • [10] Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
    Alexander T. Cohen
    Janvi Sah
    Amol D. Dhamane
    Dionne M. Hines
    Theodore Lee
    Lisa Rosenblatt
    Birol Emir
    Allison Keshishian
    Huseyin Yuce
    Xuemei Luo
    [J]. Advances in Therapy, 2023, 40 (4) : 1705 - 1735